Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant application and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institutes of Allergy and Infectious Diseases Special Emphasis Panel “Peripheral Tolerance and Autoimmunity.”
Date: June 13, 2001.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: 6700 B Rockledge Drive, Room 2223, Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Nasrin Nabavi, PhD, Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, NIAID, NIH, Room 2156, 6700B Rockledge Drive, MSC 7610, Bethesda, MD 20892-7610, 301 496-2550, email@example.com.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)Start Signature
Dated: May 15, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-12922 Filed 5-22-01; 8:45 am]
BILLING CODE 4140-01-M